1. Home
  2. HNVR vs FDMT Comparison

HNVR vs FDMT Comparison

Compare HNVR & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HNVR
  • FDMT
  • Stock Information
  • Founded
  • HNVR 2008
  • FDMT 2013
  • Country
  • HNVR United States
  • FDMT United States
  • Employees
  • HNVR N/A
  • FDMT N/A
  • Industry
  • HNVR Commercial Banks
  • FDMT Biotechnology: Pharmaceutical Preparations
  • Sector
  • HNVR Finance
  • FDMT Health Care
  • Exchange
  • HNVR Nasdaq
  • FDMT Nasdaq
  • Market Cap
  • HNVR 167.7M
  • FDMT 192.2M
  • IPO Year
  • HNVR 2022
  • FDMT 2020
  • Fundamental
  • Price
  • HNVR $21.78
  • FDMT $4.57
  • Analyst Decision
  • HNVR Buy
  • FDMT Buy
  • Analyst Count
  • HNVR 1
  • FDMT 10
  • Target Price
  • HNVR $25.00
  • FDMT $32.33
  • AVG Volume (30 Days)
  • HNVR 39.8K
  • FDMT 368.5K
  • Earning Date
  • HNVR 07-23-2025
  • FDMT 08-07-2025
  • Dividend Yield
  • HNVR 1.84%
  • FDMT N/A
  • EPS Growth
  • HNVR N/A
  • FDMT N/A
  • EPS
  • HNVR 1.52
  • FDMT N/A
  • Revenue
  • HNVR $68,211,000.00
  • FDMT $23,000.00
  • Revenue This Year
  • HNVR N/A
  • FDMT $11,586.49
  • Revenue Next Year
  • HNVR $13.18
  • FDMT N/A
  • P/E Ratio
  • HNVR $14.29
  • FDMT N/A
  • Revenue Growth
  • HNVR 9.73
  • FDMT N/A
  • 52 Week Low
  • HNVR $16.56
  • FDMT $2.24
  • 52 Week High
  • HNVR $27.14
  • FDMT $19.69
  • Technical
  • Relative Strength Index (RSI)
  • HNVR 41.94
  • FDMT 58.08
  • Support Level
  • HNVR $21.68
  • FDMT $4.15
  • Resistance Level
  • HNVR $22.68
  • FDMT $4.80
  • Average True Range (ATR)
  • HNVR 0.47
  • FDMT 0.23
  • MACD
  • HNVR -0.08
  • FDMT 0.03
  • Stochastic Oscillator
  • HNVR 22.62
  • FDMT 71.95

About HNVR Hanover Bancorp Inc.

Hanover Bancorp Inc is a United States-based banking company. It offers a full range of financial services and employs a complete suite of consumer and commercial banking products and services, including multi-family and commercial mortgages, residential loans, business loans, and lines of credit.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Share on Social Networks: